Financial Snapshot
Revenues
Revenues
Revenue YoY Change
Revenues
Expenses
Cost Of Revenues
Gross Profit
Gross Profit Margin
Gross Profit
Selling, General & Admin Expense
Research & Development
Depreciation, Depletion & Amortization
SGA Expense to Gross Profit Ratio
R&D To Gross Profit Ratio
DDA To Gross Profit Ratio
Operating Expenses Total
Operating Profits/Loss
Operational Expenses
Interest Expenses
Interest Expenses To Operating Income %
Other Expense/Income
Interest & Other Expense/Income
Income/Loss
Pretax Income
Income Tax
Net Profits/Loss
Pretax Income YoY Change
Income Tax Rate
Net Profits/Loss YoY Change
Basic EPS
Net Income To Revenue Ratio
Pretax & Net Income
Assets & Liabilities
Cash & Short-Term Investments
Cash & Equivalents
Cash To Operating Expenses Ratio
Inventory
Receivables
Total Short-Term Assets
Property, Plant And Equipment
Long-Term Investments
Total Long-Term Assets
Total Assets
Net Income To Total Assets Percentage
Accounts Payable
Short-Term Debt
Long Term Debt Due
Total Short-Term Liabilities
Long-Term Debt
Other Long-Term Liabilities
Total Long-Term Liabilities
Total Liabilities
Short-Term To Long-Term Debt Ratio
Short-Term Assets To Debt Ratio
Long-Term Debt To Net Income Ratio
Assets & Liabilities
Ownership
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares
Stock Issuance & Repurchase
Ownership Data
Return On Shareholders' Equity
Book Value
Free Cash Flow
Free Cash Flow YoY
Free Cash Flow Margin
Dividends
Dividends
Stock Price
About Vireo Growth Inc.
Vireo Growth Inc is a US-based company operating in Pharmaceuticals industry. The company is headquartered in Minneapolis, Minnesota and currently employs 490 full-time employees. The company went IPO on 2005-05-09. Vireo Growth Inc., formerly Goodness Growth Holdings, Inc., is a cannabis company. The firm has operations in four markets in Maryland, Minnesota, New Mexico, and New York. The firm is science-focused and provides patients and adult-use customers with cannabis-based products. The company cultivates and manufactures pharmaceutical-grade cannabis extracts and sells its products at both Company-owned and third-party dispensaries to qualifying patients and adult-use customers. The company has developed proprietary cannabis strains, cultivation methods, carbon dioxide extraction, ethanol extraction, and other processes related to the production, refinement, and packaging of cannabis products. The firm manufactures, assembles, and packages cannabis finished goods across a range of product segments, including Inhalable, Ingestible, and Topicals. Its brands include Vireo Spectrum, Vireo Selects, 1937, Boundary Waters, Hi-Color, Kings and Queens, and various other flower and trim brands.
Industry: Pharmaceutical Preparations Peers: Lyra Therapeutics, Inc. Citius Pharmaceuticals, Inc. JOHNSON & JOHNSON ZEVRA THERAPEUTICS, INC. MARIMED INC. Rain Oncology Inc. ProPhase Labs, Inc. scPharmaceuticals Inc. Terns Pharmaceuticals, Inc.
